IntelliPharmaCeutics to Present at Upcoming Cowen Healthcare Royalty Partners and Roth Conferences
TORONTO, Feb. 17, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that management will be presenting at two upcoming investor conferences.